Coronary Artery Disease Therapeutics Market trend, outlook 2025
Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1799
Coronary Artery Disease Therapeutics Market Drivers:-
The global market is expected to witness significant growth due to robust pipeline of drugs over the forecast period (2018-2026). For instance, hydroxychloroquine sulfate tablets sponsored by first affiliated hospital of Xi’an Jiaotong university, China is in the fourth phase of clinical trials, this drug suppresses symptoms of coronary artery disease. Atorvastatin sponsored by university health network, Toronto has completed phase two clinical trials in 2014, this drug reduces the risk of heart attack and myocardial infraction. PADMA 28 sponsored by University hospital Inselsiptal, Berne has completed phase 2 clinical trials in 2013, this drug has beneficial effect on arterial system, the autonomic nervous system and blood inflammatory markers in patients with coronary artery disease.
Furthermore, approval of new drugs for coronary artery disease is another factor driving growth of the coronary artery disease therapeutics market. For instance, in 2016, the U.S. FDA approved Yosprala (Aspirin and Omeprazole) by Aralez Pharmaceuticals, a Canada-based company, this drug is used to prevent cardiovascular diseases. In 2015, FDA approved Repatha by Amgen Inc. This drug is used to treat high cholesterol. In 2015, FDA approved Prestalia by Symplmed Pharmaceuticals LLC, this drug is used to treat hypertension for people suffering with heart disorders. Later in 2017, Prestalia was acquired by Marina Biotech Inc.
However, high cost of new drugs is restraining growth of coronary artery disease therapeutics market. For instance, Entresto was launched by Novartis, a U.S.-based company, indicated for preventing heart failures. It is priced at US$ 492 for 60 tablets, which is not affordable to low and middle income population.
Request for TOC : https://www.coherentmarketinsights.com/ongoing-insight/toc/1799
Coronary Artery Disease Therapeutics Market Regional Analysis:-
North America is expected to hold dominant position in global coronary artery disease therapeutics market due to high prevalence of coronary artery disease. According to a survey conducted by Centers for disease control and prevention (CDC), in 2015, coronary heart disease kills more than 370,000 people annually in the U.S. out of which more than 92% had chest pain as a major symptom. According to a study conducted by American College of Cardiology, in 2017, more than 790000 people experience heart attack annually in the U.S. out of this around 47% people were reported to have hypertension and around 34% were reported to have high blood pressure. Therefore, high prevalence of chronic diseases are expected to drive growth of this market over the forecast period. Asia Pacific coronary artery disease therapeutics market is projected to witness significant growth due to FDA approvals for generic drugs. For instance, in 2017, Lupin, India-based Company received FDA approval to launch generic version of Nadolol Tablets, indicated for the treatment of hypertension and angina pectoris.
Key players operating in coronary artery disease therapeutics market include Astra Zeneca, Gilead, Novartis, Pfizer, Bayer, Merck & Co, Glaxo Smith Kline, and Mylan N.V.
Coronary Artery Disease Therapeutics Market Taxonomy:-
The global market is segmented based on drug type, distribution channel and region.
By Drug Type:-
Calcium Channel Blockers
By Distribution Channel:-
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Coronary Artery Disease Therapeutics Market trend, outlook 2025 here
News-ID: 1098905 • Views: 427
More Releases from Coherent Market Insights - Pharmaceutical Industry
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around
More Releases for Coronary
Cardiac Guidewire and Catheters Market | Coronary Guidewires
Global Cardiac Guide Wire and Catheters Market is Expected to Increse around US$ XX Mn by 2024, Due to Increasing Cardiovascular Disease Such as Heart Attack and Atherosclerosis Analyst Speak: “The Global Cardiac Guide Wire and Catheters Market is anticipated to reach about US$ XX Mn by 2024, and anticipated to expanding at a CAGR over six years of forecast period 2019-2024” due to rise in occurrence of cardiovascular diseases and
Coronary Stents Market - Competitive Strategies 2025
Global Coronary Stents Market: Snapshot The market for coronary stents has been gaining significant traction across the world. Technological advancements, increasing burden of CAD, and the rising base of geriatric population are the main factors that have been fueling the demand for coronary stents substantially. Apart from these, the augmenting demand for minimally invasive procedures and the rising number of percutaneous coronary intervention (PCI) procedures are also supplementing to the growth
Coronary Stent Market Influential Share of 2025
Global Coronary Stent Market: Overview The alarming rise in the number of cardiovascular diseases has become the primary growth driver for the global coronary stent market. Changing lifestyles that are characterized by high stress levels, alcohol consumption, smoking, and poor choice of food habits have collectively led to questionable heart health for the global market. The World Health Organization states that the cardiovascular diseases have become the leading cause of deaths
Coronary Stents Market Is Thriving Worldwide
HTF MI published a new industry research that focuses on Coronary Stents market and delivers in-depth market analysis and future prospects of Global Coronary Stents market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. The study is
Global Coronary Guidewire Sales Market Report 2017
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Coronary Guidewire for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Coronary Guidewire market competition by top manufacturers/players, with Coronary Guidewire sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including • Abbott Vascular (US) • Boston Scientific (US) • Cordis (US) • Medtronic (US) • Terumo Medical (US) • Teleflex